Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 12 studies | 55% ± 21% | |
astrocyte | 10 studies | 41% ± 18% | |
fibroblast | 5 studies | 21% ± 6% | |
GABAergic neuron | 5 studies | 39% ± 15% | |
retina horizontal cell | 4 studies | 57% ± 19% | |
hepatocyte | 3 studies | 49% ± 19% | |
glutamatergic neuron | 3 studies | 23% ± 5% | |
interneuron | 3 studies | 29% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 480.01 | 1443 / 1445 | 67% | 2.01 | 122 / 183 |
thymus | 98% | 217.75 | 643 / 653 | 68% | 4.50 | 409 / 605 |
ovary | 100% | 427.96 | 180 / 180 | 63% | 1.57 | 271 / 430 |
uterus | 98% | 373.12 | 166 / 170 | 63% | 2.39 | 289 / 459 |
liver | 100% | 1173.55 | 226 / 226 | 59% | 3.57 | 238 / 406 |
prostate | 100% | 294.80 | 244 / 245 | 52% | 0.80 | 263 / 502 |
brain | 90% | 247.95 | 2391 / 2642 | 61% | 1.62 | 427 / 705 |
breast | 91% | 189.02 | 416 / 459 | 60% | 1.80 | 672 / 1118 |
lung | 99% | 398.84 | 575 / 578 | 50% | 1.76 | 579 / 1155 |
stomach | 98% | 201.26 | 353 / 359 | 46% | 1.17 | 132 / 286 |
intestine | 94% | 229.32 | 911 / 966 | 39% | 0.81 | 208 / 527 |
pancreas | 100% | 761.25 | 328 / 328 | 33% | 0.54 | 59 / 178 |
skin | 72% | 392.61 | 1304 / 1809 | 60% | 2.18 | 284 / 472 |
bladder | 100% | 426.90 | 21 / 21 | 27% | 0.59 | 136 / 504 |
adrenal gland | 100% | 290.48 | 258 / 258 | 14% | 0.50 | 33 / 230 |
kidney | 91% | 191.87 | 81 / 89 | 22% | 0.41 | 198 / 901 |
spleen | 100% | 269.49 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 986.32 | 793 / 803 | 0% | 0 | 0 / 0 |
adipose | 93% | 193.25 | 1117 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 170.06 | 1222 / 1335 | 0% | 0 | 0 / 0 |
heart | 78% | 158.57 | 673 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 2.82 | 34 / 45 |
peripheral blood | 27% | 42.74 | 248 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.18 | 8 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.42 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0006508 | Biological process | proteolysis |
GO_0005576 | Cellular component | extracellular region |
GO_0031012 | Cellular component | extracellular matrix |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ADAMTS17 |
Protein name | A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-) ADAM metallopeptidase with thrombospondin type 1 motif 17 |
Synonyms | |
Description | |
Accessions | H0YMH1 ENST00000561355.2 ENST00000268070.9 [Q8TE56-1] ENST00000558960.1 ENST00000568565.2 H3BRA9 H3BV94 Q8TE56 |